Last updated on April 2019

An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Candidemia
  • Age: Between 18 - 80 Years
  • Gender: Male or Female

Key Inclusion Criteria:

  • Provision of written consent
  • Ages 18-80 inclusive, male or female
  • New diagnosis of candidemia
  • Able to have pre-existing intravascular catheters removed and replaced (as necessary)

Key Exclusion Criteria:

  • neutropenia
  • deep-seated Candida-related infections
  • hepatosplenic candidiasis
  • received more than 2 days of prior systemic antifungal treatment for current candidemia episode
  • severe hepatic impairment

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.